Web Analytics
Cổ phiếu VKTX (NASDAQ) | VIKING THERAPEUTICS INC – Phân tích Deepscope
MARKET

Select Market Data Region

VKTX — VIKING THERAPEUTICS INC (Healthcare >> Biotechnology)

VKTX FAQ

What is VKTX's ROE?

VIKING THERAPEUTICS INC reports a Return on Equity (ROE) of -94.11%.

What is VKTX's dividend yield?

VIKING THERAPEUTICS INC offers a dividend yield of 0.00%.

What is VKTX's Deepscope Quality Score?

Deepscope rates VKTX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy VKTX?

Deepscope's AI Timing Score for VKTX is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does VKTX belong to?

VIKING THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-09 | FS: 2026-03-31)

VKTX

VIKING THERAPEUTICS INC
USD 29.23
-0.01 (-0.03%) Day Change
0.21
D/E
-94.1%
ROE
-77.7%
ROA
0.00%
Div Yield
USD 29.23
Price
-0.01 (-0.03%)
Day Change
NEWS SCORE: 99

VKTX Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 23) và Thời điểm mua ...(Sign In to See)...

23

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng 45%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 1.75 From 30 days period
  Watch Rate 0.18 From 30 days period
  News Score 99
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 29.23
  PBV / Sector
6.76 / 4.71
  Earning Per Share -4.07
  PE / Sector
N/A / 17.58
  PEG or PE/Growth / Sector
N/A / 0.53
  Average 1M Daily Value
57.83 M
  Average 1W Daily Value
59.26 M
Yếu tố Kỹ thuật 14%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 37%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
N/A / 468.85
  NPM Average (%) / Sector
N/A / -1,531.69
  NPM Change Average (%) / Sector
N/A / 5,028.65
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-77.66 / 31.69
  ROA Average (%) / Sector
-40.84 / -353.18
  ROA Change Average (%) / Sector
69.65 / 5,214.65
GREAT
  ROE (%) / Sector
-94.11 / 10.58
  ROE Average (%) / Sector
-46.98 / 27.64
  ROE Change Average (%) / Sector
80.10 / 2,048.88
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 3.68
Chi tiết đăng ký
X
  Analyze Date 2026-06-10 09:43:43
  Symbol VKTX
  Name VIKING THERAPEUTICS INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 116.11 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 3,394.93 / 8,889.42
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 9920 Pacific Heights Boulevard, San Diego, CA, United States, 92121

Phone: 858 704 4660

Website: https://www.vikingtherapeutics.com

Employees: 59

Sector: Healthcare >> Biotechnology

Description: Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

ME vs SECTOR Healthcare >> Biotechnology

VKTX (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
VKTX
VKTX
USD 29.23 (-0.03%)
+ Watch + Port Chart